Z-0330-2022 Class II Terminated

Recalled by Siemens Healthcare Diagnostics, Inc. — Newark, DE

FDA device recall Z-0330-2022 was initiated by Siemens Healthcare Diagnostics, Inc. on October 15, 2021 and is designated Class II. Reason for recall: Incorrect Default Hemolysis, Icterus or Lipemia (HIL) Index for Five Dimension Vista Assays The recall status is terminated (terminated May 13, 2024). Affected quantity: 1407 units.

Recall Details

Product Type
Devices
Report Date
December 8, 2021
Initiation Date
October 15, 2021
Termination Date
May 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1407 units

Product Description

Dimension Vista 1500 In-vitro diagnostic device intended to duplicate manual analytical procedures such as pipetting, mixing, heating, and measuring spectral intensities to determine a variety of analytes in human body fluid SMN: 10444801(US) and 10444802 (OUS)

Reason for Recall

Incorrect Default Hemolysis, Icterus or Lipemia (HIL) Index for Five Dimension Vista Assays

Distribution Pattern

Worldwide distribution - US Nationwide distribution and the countries of DE, ES, FR, IT, CA, NL, JP, PT, AU, CZ, AT, DK, SI, BE, SK, QA, SA, KR, CH.

Code Information

All software versions prior to 3.10.2. GTIN: 00630414949741 and 00630414945460 (GTIN + Instrument Serial Number = Unique Device Identification (UDI)